Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Research Article

Free Access

Neuropsychiatric Syndromes in Dementia

Results from the European Alzheimer Disease Consortium: Part I
Aalten P.a · Verhey F.R.J.a · Boziki M.b · Bullock R.c · Byrne E.J.d · Camus V.f · Caputo M.i · Collins D.d · De Deyn P.P.m · Elina K.b · Frisoni G.j · Girtler N.k · Holmes C.e · Hurt C.d · Marriott A.c · Mecocci P.i · Nobili F.k · Ousset P.J.g · Reynish E.g · Salmon E.l · Tsolaki M.b · Vellas B.g · Robert P.H.h

Author affiliations

aDepartment of Psychiatry and Neuropsychology, Alzheimer Centre Limburg, Maastricht University Hospital, Maastricht, The Netherlands; bDepartment of Neurology, Thessaloniki, Greece; cKingshill Research Centre, Victoria Hospital, Swindon, dDivision of Psychiatry, University of Manchester, Education and Research Centre, Wythenshawe Hospital, Manchester, and eClinical Neurosciences Research Division, Memory Assessment and Research Centre, University of Southampton, Southampton, UK; fClinique Psychiatrique Universitaire, CRU de Tours et Université François Rabelais, Tours, gDepartment of Internal and Geriatrics Medicine, Hôpitaux de Toulouse, Toulouse, and hCentre Mémoire de Ressources et de Recherche, CHU, Hôpital Pasteur, Université de Nice-Sophia Antipolis, Nice, France; iInstitute of Gerontology and Geriatrics, University of Perugia, Perugia, jNational Centre for Research and Care of Alzheimer’s and Mental Diseases, Brescia, and kClinical Neurophysiology Service, Department of Internal Medicine, University of Genoa, Genoa, Italy; lUniversity of Liège, Cyclotron Research Centre, and CHU Liège, Memory Centre, Liège, and mDepartment of Neurology, ZNA and Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium

Corresponding Author

Dr. P. Aalten

Department of Psychiatry and Neuropsychology, Maastricht University Hospital

PO Box 5800

NL–6202 AZ Maastricht (The Netherlands)

Tel. +31 43 388 4104, Fax +31 43 387 5444, E-Mail p.aalten@np.unimaas.nl

Related Articles for ""

Dement Geriatr Cogn Disord 2007;24:457–463

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Abstract

Background/Aims: The aim of this study was to identify neuropsychiatric subsyndromes of the Neuropsychiatric Inventory in a large sample of outpatients with Alzheimer’s disease (AD). Methods: Cross-sectional data of 2,354 patients with AD from 12 centres from the European Alzheimer’s Disease Consortium were collected. Principal component analysis was used for factor analysis. Results: The results showed the presence of 4 neuropsychiatric subsyndromes: hyperactivity, psychosis, affective symptoms and apathy. The subsyndrome apathy was the most common, occurring in almost 65% of the patients. Conclusion: This large study has provided additional robust evidence for the existence of neuropsychiatric subsyndromes in AD.

© 2007 S. Karger AG, Basel


References

  1. Aalten P, De Vugt ME, Lousberg R, Korten E, Jaspers N, Senden B, Jolles J, Verhey FR: Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord 2003;15:99–105.
  2. Robert PH, Verhey FR, Byrne EJ, Hurt C, De Deyn PP, Nobili F, Riello R, Rodriguez G, Frisoni GB, Tsolaki M, Kyriazopoulou N, Bullock R, Burns A, Vellas B: Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects: consensus paper of the European Alzheimer disease consortium. Eur Psychiatry 2005;20:490–496.
  3. Herrmann N, Rabheru K, Wang J, Binder C: Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials. Am J Geriatr Psychiatry 2005;13:527–534.
  4. Gauthier S, Wirth Y, Mobius HJ: Effects of memantine on behavioural symptoms in Alzheimer’s disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psychiatry 2005;20:459–464.
  5. Kaufer D, Cummings JL, Christine D: Differential neuropsychiatric symptom responses to tacrine in Alzheimer’s disease: relationship to dementia severity. J Neuropsychiatry Clin Neurosci 1998;10:55–63.
  6. Benoit M, Staccini P, Robert PH, Brocker P, Benhamidat T, Bertogliati C, Lechowski L, Andrieu S, Vellas B: Frequence et analyse factorielle des troubles du comportement dans la maladie d’Alzheimer. Rev Med Interne 2003;24:314–324.
  7. Frisoni GB, Rozzini L, Gozzetti A, Binetti G, Zanetti O, Bianchetti A, Trabucchi M, Cummings JL: Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Disord 1999;10:130–138.
  8. Devanand DP, Brockington CD, Moody BJ, Brown RP, Mayeux R, Endicott J, Sackeim HA: Behavioral syndromes in Alzheimer’s disease. Int Psychogeriatr 1992;4(suppl 2): 161–184.
    External Resources
  9. Hope T, Keene J, Fairburn C, McShane R, Jacoby R: Behaviour changes in dementia. 2. Are there behavioural syndromes? Int J Geriatr Psychiatry 1997;12:1074–1078.
  10. McShane R: What are the syndromes of behavioral and psychological symptoms in dementia? Int Psychogeriatr 2000;12(suppl 1): 147–153.
    External Resources
  11. Fuh JL, Wang SJ, Cummings JL: Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia. J Neurol Neurosurg Psychiatry 2005;76:1337–1341.
  12. Schreinzer D, Ballaban T, Brannath W, Lang T, Hilger E, Fasching P, Fischer P: Components of behavioral pathology in dementia. Int J Geriatr Psychiatry 2005;20:137–145.
  13. Mirakhur A, Craig D, Hart DJ, McLlroy SP, Passmore AP: Behavioural and psychological syndromes in Alzheimer’s disease. Int J Geriatr Psychiatry 2004;19:1035–1039.
  14. Lyketsos CG, Sheppard JM, Steinberg M, Tschanz JA, Norton MC, Steffens DC, Breitner JC: Neuropsychiatric disturbance in Alzheimer’s disease clusters into three groups: the Cache County study. Int J Geriatr Psychiatry 2001;16:1043–1053.
  15. Lyketsos CG, Breitner JC, Rabins PV: An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer’s disease. Int J Geriatr Psychiatry 2001;16:1037–1042.
  16. Fuh JL, Liu CK, Mega MS, Wang SJ, Cummings JL: Behavioral disorders and caregivers’ reaction in Taiwanese patients with Alzheimer’s disease. Int Psychogeriatr 2001;13:121–128.
  17. Spalletta G, Baldinetti F, Buccione I, Fadda L, Perri R, Scalmana S, Serra L, Caltagirone C: Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer’s disease. J Neurol 2004;251:688–695.
  18. Matsui T, Nakaaki S, Murata Y, Sato J, Shinagawa Y, Tatsumi H, Furukawa TA: Determinants of the quality of life in Alzheimer’s disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer’s disease scale. Dement Geriatr Cogn Disord 2006;21:182–191.
  19. Lange RT, Hopp GA, Kang N: Psychometric properties and factor structure of the Neuropsychiatric Inventory Nursing Home version in an elderly neuropsychiatric population. Int J Geriatr Psychiatry 2004;19:440–448.
  20. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
  21. Cummings JL: The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997;48(suppl 6):S10–S16.
    External Resources
  22. Cummings JL, McPherson S: Neuropsychiatric assessment of Alzheimer’s disease and related dementias. Aging (Milano) 2001;13:240–246.
  23. Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR: The course of neuropsychiatric symptoms in dementia. I. Findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry 2005;20:523–530.
  24. Ballard CG, Margallo-Lana M, Fossey J, Reichelt K, Myint P, Potkins D, O’Brien J: A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments. J Clin Psychiatry 2001;62:631–636.
  25. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475–1483.
  26. Steinberg M, Sheppard JM, Tschanz JT, Norton MC, Steffens DC, Breitner JC, Lyketsos CG: The incidence of mental and behavioral disturbances in dementia: the cache county study. J Neuropsychiatry Clin Neurosci 2003;15:340–345.
  27. Steinberg M, Tschanz JT, Corcoran C, Steffens DC, Norton MC, Lyketsos CG, Breitner JC: The persistence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry 2004;19:19–26.
  28. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  29. Marin RS, Firinciogullari S, Biedrzycki RC: The sources of convergence between measures of apathy and depression. J Affect Disord 1993;28:117–124.
  30. Starkstein SE, Ingram L, Garau ML, Mizrahi R: On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry 2005;76:1070–1074.
  31. Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Brocker P, Bedoucha P: The apathy inventory: assessment of apathy and awareness in Alzheimer’s disease, Parkinson’s disease and mild cognitive impairment. Int J Geriatr Psychiatry 2002;17:1099–1105.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Published online: November 07, 2007
Issue release date: November 2007

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 4

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.